139 related articles for article (PubMed ID: 19070594)
1. Nmur1-/- mice are not protected from cutaneous inflammation.
Abbondanzo SJ; Manfra DJ; Chen SC; Pinzon-Ortiz M; Sun Y; Phillips JE; Laverty M; Vassileva G; Hu W; Yang S; Gustafson EL; Fine JS; Hedrick JA
Biochem Biophys Res Commun; 2009 Jan; 378(4):777-82. PubMed ID: 19070594
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.
Moriyama M; Sato T; Inoue H; Fukuyama S; Teranishi H; Kangawa K; Kano T; Yoshimura A; Kojima M
J Exp Med; 2005 Jul; 202(2):217-24. PubMed ID: 16009716
[TBL] [Abstract][Full Text] [Related]
3. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses.
Torres R; Croll SD; Vercollone J; Reinhardt J; Griffiths J; Zabski S; Anderson KD; Adams NC; Gowen L; Sleeman MW; Valenzuela DM; Wiegand SJ; Yancopoulos GD; Murphy AJ
Pain; 2007 Aug; 130(3):267-278. PubMed ID: 17379411
[TBL] [Abstract][Full Text] [Related]
4. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice.
Egecioglu E; Ploj K; Xu X; Bjursell M; Salomé N; Andersson N; Ohlsson C; Taube M; Hansson C; Bohlooly-Y M; Morgan DG; Dickson SL
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E708-16. PubMed ID: 19584200
[TBL] [Abstract][Full Text] [Related]
5. Two chicken neuromedin U receptors: characterization of primary structure, biological activity and tissue distribution.
Yamamoto I; Nakao N; Kaiya H; Miyazato M; Tsushima N; Arai T; Tanaka M
Gen Comp Endocrinol; 2011 Nov; 174(2):116-23. PubMed ID: 21878335
[TBL] [Abstract][Full Text] [Related]
6. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2.
Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR
J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576
[TBL] [Abstract][Full Text] [Related]
7. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform.
Rucinski M; Ziolkowska A; Tyczewska M; Szyszka M; Malendowicz LK
Int J Mol Med; 2008 Sep; 22(3):363-8. PubMed ID: 18698496
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics of the rat neuromedin U receptor 1 reveals a naturally occurring deleterious allele.
Panetta R; Meury L; Cao CQ; Puma C; Mennicken F; Cassar PA; Laird J; Groblewski T
Physiol Genomics; 2013 Jan; 45(2):89-97. PubMed ID: 23212943
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression patterns of neuromedin U and its receptors in pigs.
Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat.
Rucinski M; Ziolkowska A; Neri G; Trejter M; Zemleduch T; Tyczewska M; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2007 Aug; 20(2):255-9. PubMed ID: 17611645
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
[TBL] [Abstract][Full Text] [Related]
12. Effects of peripherally administered neuromedin U on energy and glucose homeostasis.
Peier AM; Desai K; Hubert J; Du X; Yang L; Qian Y; Kosinski JR; Metzger JM; Pocai A; Nawrocki AR; Langdon RB; Marsh DJ
Endocrinology; 2011 Jul; 152(7):2644-54. PubMed ID: 21586559
[TBL] [Abstract][Full Text] [Related]
13. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
[TBL] [Abstract][Full Text] [Related]
14. Neuromedin U: physiology, pharmacology and therapeutic potential.
Budhiraja S; Chugh A
Fundam Clin Pharmacol; 2009 Apr; 23(2):149-57. PubMed ID: 19645813
[TBL] [Abstract][Full Text] [Related]
15. Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.
Zeng H; Gragerov A; Hohmann JG; Pavlova MN; Schimpf BA; Xu H; Wu LJ; Toyoda H; Zhao MG; Rohde AD; Gragerova G; Onrust R; Bergmann JE; Zhuo M; Gaitanaris GA
Mol Cell Biol; 2006 Dec; 26(24):9352-63. PubMed ID: 17030627
[TBL] [Abstract][Full Text] [Related]
16. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
17. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
[TBL] [Abstract][Full Text] [Related]
18. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).
Peier A; Kosinski J; Cox-York K; Qian Y; Desai K; Feng Y; Trivedi P; Hastings N; Marsh DJ
Endocrinology; 2009 Jul; 150(7):3101-9. PubMed ID: 19324999
[TBL] [Abstract][Full Text] [Related]
19. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
Lin TY; Huang WL; Lee WY; Luo CW
PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
[TBL] [Abstract][Full Text] [Related]
20. PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.
Ingallinella P; Peier AM; Pocai A; Marco AD; Desai K; Zytko K; Qian Y; Du X; Cellucci A; Monteagudo E; Laufer R; Bianchi E; Marsh DJ; Pessi A
Bioorg Med Chem; 2012 Aug; 20(15):4751-9. PubMed ID: 22771182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
